LM Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.79M Buy
5,649
+957
+20% +$978K 0.78% 25
2026
Q1
$5.1K Sell
4,692
-801
-15% -$812K 0.08% 127
2025
Q4
$5.11K Buy
5,493
+458
+9% +$438K 0.09% 124
2025
Q3
$3.84M Buy
5,035
+4
+0.1% +$2.98K 0.55% 36
2025
Q2
$3.92M Sell
5,031
-847
-14% -$658K 0.5% 30
2025
Q1
$4.86M Sell
5,878
-260
-4% -$216K 0.87% 20
2024
Q4
$4.74M Buy
6,138
+1,254
+26% +$1.04M 0.85% 21
2024
Q3
$4.33M Sell
4,884
-110
-2% -$98.9K 0.88% 22
2024
Q2
$4.52M Sell
4,994
-326
-6% -$261K 0.8% 22
2024
Q1
$4.14M Sell
5,320
-48
-0.9% -$34.2K 0.66% 30
2023
Q4
$3.13M Buy
+5,368
New +$3.13M 0.63% 33

Other funds holding LLY

LM Advisors's LLY Position: Q2 2026 in Review

LM Advisors increased its Eli Lilly (LLY) stake by 20% in Q2 2026, buying an estimated $978K and bringing the position to 5,649 shares worth $6.79M. The position accounts for 0.78% of the portfolio, ranked #25.

LM Advisors first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • LM Advisors held 5,649 shares of Eli Lilly worth $6.79M as of Q2 2026.
  • LM Advisors bought 957 Eli Lilly shares in Q2 2026, an estimated $978K.
  • Eli Lilly made up 0.78% of LM Advisors's portfolio in Q2 2026, its #25 holding.
  • LM Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on LM Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.